References

Abikoff, H. et al (2004) Social functioning in children with ADHD treated with long term methylphenidate and multi-modal psychosocial treatment, Journal of the American Academy of Child and Adolescent Psychiatry, 43, 820-829.

Akhondzadeh, S., Mohammadi, M.R., Khademi, M. (2004) Zinc Sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial. BMC Psychiatry, 4, 9.

American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders, 4th Edition, (DSM-1V). American Psychiatric Association, Washington, DC.

American Academy of Child and Adolescent Psychiatry (1997). Practice parameters for the assessment and treatment of children, adolescents and adults with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 36 (10, supplement), 85S-121S.

American Academy of Child and Adolescent Psychiatry (2007). Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 894-921.

American Academy of Pediatrics (2000). Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit hyperactivity disorder. Pediatrics, 105, 1158-1170.

American Academy of Pediatrics (2001). Clinical practice guideline: Treatment of the school-aged child with attention-deficit hyperactivity disorder. Pediatrics, 108, 1033-1044.

Armour, D. & Paton, C. (2004) Melatonin in the treatment of insomnia in children and adolescents. Psychiatric Bulletin, 28, 222-224.

Asherson, P. & Kooij, J.J.S. (2006) Recognition of Adult Attention Deficit Hyperactivity Disorder in the United Kingdom and Netherlands. In ACAMH Occasional Papers No.24, The ADHD Spectrum. P.61-71.

Barkley, R.A. (1990). Attention Deficit Hyperactivity Disorder: A Handbook For Diagnosis and Treatment. New York : Guilford Press..

Baird, G., Charman, T. & Santosh, P.J. (2001) Clinical considerations in the diagnosis of autism spectrum disorders. Indian Journal of Paediatrics, 68, 439-449.

Biederman, J., Baldessarini, R.J., Wright, V. et al (1989) A double-blind placebo controlled study of desipramine in the treatment of ADD: 1. Efficacy. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 777-784.

Beiderman J, Newcorn J and Sprich S (1991). Co-morbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety and other disorders. American Journal of Psychiatry, 148, 564-577.

British National Formulary (2004). 48. London: British Medical Association and Royal Pharmaceutical Society of Great Britain.

Cantwell, D. (1996). Attention deficit disorder: A review of the past 10 years. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 978-987.

Cantwell, D. & Scatterfield, J. (1978) The prevalence of academic underachievement in hyperactive children. Journal of Paediatric Psychology, 3, 163-171.

Coghill, D. (2006) Making the most of scant resources: The development of an effective ADHD service. In ACAMH Occasional Papers No.24, The ADHD Spectrum. P.39-49.

Curran, S. & Taylor, E. (2000). Attention deficit-hyperactivity disorder: biological causes and treatments. Current Opinion in Psychiatry, 13, 397-402.

DuPaul, G.J. and Eckert, T.L. (1997). The effects of school-based interventions for attention deficit hyperactivity disorder: A meta-analysis. School Psychology Review, 26, 5-27.

Ehlers, S. and Gillberg, C (1993) The epidemiology of Asperger syndrome. A total population study. Journal of Child Psychology and Psychiatry and Allied Disciplines. 34, 1327-50.

Fitzgerald, M. & Corvin, A. (2001) Diagnosis and differential diagnosis of Asperger syndrome. Advances in Psychiatric Treatment, 7, 310-318.

Frankel, F., Myatt, R., Cantwell, D. and Feinberg, D. (1997). Parent-assisted transfer of social skills training: Effects on children with and without attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 1056-1064.

Gillberg, C., Rasmussen, P., Carlstrom, G., Svenson, B. & Waldenstrom, E. (1982) Perceptual, motor and attentional deficits in six year old children: Epidemiological aspects. Journal of Child Psychology and Psychiatry, 23, 131-144.

Gillberg, I.C. & Gillberg, C (1989a) Asperger syndrome: Some epidemiological considerations. Journal of Child Psychology and Psychiatry, 30, 631-638.

Gillberg, I.C. & Gillberg, C. (1989b) Children with preschool minor neurodevelopmental disorders: 1V Behaviour and school achievement at age 13. Developmental Medicine and Child Neurology, 31, 3-13.

Gillberg, C. (1992) Autism and autistic-like conditions: subclasses among disorders of empathy. Journal of Child Psychology and Psychiatry, 33, 813-842.

Gillberg, C. (1995) Clinical Child Neuropsychiatry, Cambridge: Cambridge University Press.

Gillberg C. (1998) Hyperactivity, inattention and motor control problems: prevalence, comorbidity and background factors. Folia Phoniatrica et Logopaedia, 50, 107-17.

Greene, R.W., Biederman, J., Faraone, S.V. et al (1996) Toward a new psychometric definition of social disability in children with attention deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 571-578.

Greenhill, L.L., Halperin, J.M. & Abikoff, H. (1999). Stimulant Medications. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 503-512.

Greenhill, L.L., Swanson, J.M., Vitiello, B. et al. (2001). Impairment and deportment responses to different methylphenidate doses in children with ADHD: The MTA titration trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 180-187.

Greenhill et al (2002) Practice parameter for the use of stimulant medications in the treatment of children, adolescents and adults, Journal of the American Academy of Child and Adolescent Psychiatry, 41(2, supplement), 26S-49S.

Haddad, P.M. & Garralda, M.E. (1992). Hyperkinetic syndrome and disruptive early experiences. British Journal of Psychiatry, 161, 700-703.

Hechtman, L. et al (2004) Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multi-modal psychosocial treatment, Journal of the American Academy of Child and Adolescent Psychiatry, 43, 812-819.

Hill, P. & Taylor, E. (2001). An auditable protocol for treating attention deficit/hyperactivity disorder. Archives of Disease in Childhood, 84, 404-409.

Jadad, A.R., Boyle, M., Cunningham, C. et al. (1999). Treatment of Attention-Deficit/Hyperactivity Disorder. Evidence Report/Technology Assessment: Number 11(Prepared by McMaster University under contract No.290-97-0017). Agency for Health Care Policy and Research and Quality.

Jensen, P.S., Arnold, L.E., Richters, J.E. et al. (1999a). A 14-month randomized clinical trial of treatment strategies for children with attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1073-1086.

Jensen, P.S., Arnold, L.E., Richters, J.E. et al. (1999b). Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the multi-modal treatment study of children with attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1088-1096.

Jensen, P.S., Hinshaw, S.P., Kraemer, H.C. et al. (2001). ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 147-158.

Joughin C and Zwi M (1999). Focus on the use of stimulants in children with attention deficit hyperactivity disorder. Primary Evidence-base briefing No.1. The Royal College of Psychiatrists, London.

Kaplan, B.J., Crawford, S.G., Gardner, B. & Farrelly, G. (2002) Treatment of mood lability and explosive rage with minerals and vitamins: two case studies in children. Journal of Child and Adolescent Psychopharmacology, 12(3), 205-19

Lambert, N. & Sandoval, J. (1980) The prevalence of learning disabilities in a sample of children considered hyperactive. Journal of Abnormal Child Psychology, 8, 33-50.

Lord J and Paisley S (2000). The clinical effectiveness and cost-effectiveness of methylphenidate for hyperactivity in childhood. National Institute for Clinical Excellence, Version 2, London.

Martin, N., McDougall, M., & Hay, D.A. (2008) What are the key directions in the genetics of attention deficit hyperactivity disorder? Current Opinion in Psychiatry, 21, 356-361.

Milberger, S., Biederman, J. Faraone, S.V. et al (1996) Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in childhood?. American Journal of Psychiatry, 153(9), 1138-42.

National Institute for Health and Clinical Excellence (2008) Attention Deficit Hyperactivity Disorder: diagnosis and management of ADHD in children, young people and adults. clinical guideline 72. National Institute for Health and Clinical Excellence. www.nice.org.uk  

National Institute for Clinical Excellence (2000). Guidance on the use of methylphenidate (Ritalin, Equasym) for attention deficit/hyperactivity disorder (ADHD). In Childhood Technology Appraisal Guidance-no 13. National Institute for Clinical Excellence. London.

National Institute for Health and Clinical Excellence (2006) Review of technology Appraisal 13- methylphenidate, atomoxetine and dexamphetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents. available via www.nice.org.uk/TA098.  

Overmeyer, S. & Taylor, E. (1999). Annotation: Principles of Treatment for Hyperkinetic Disorder: Practice approaches for the UK. Journal of Child Psychology and Psychiatry, 40, 1147-1157.

Pelham, W.E., Wheeler, T. & Chronis, A. (1998). Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. Journal of Clinical Child Psychology, 27, 190-205.

Pliszka, S.R., Greenhill, L.L., Crismon, M.L. et al. (2000a). The Texas children's medication algorithm project: report of the Texas consensus conference panel on medication treatment of childhood attention-deficit/hyperactivity disorder. Part 1. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 908-919.

Pliszka, S.R., Greenhill, L.L., Crismon, M.L. et al. (2000b). The Texas children's medication algorithm project: report of the Texas consensus conference panel on medication treatment of childhood attention-deficit/hyperactivity disorder. Part 11: tactics. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 920-927.

Pliszka, S.R., Crismon, M.L., Hughes C.W. et al. (2006). The Texas children's medication algorithm project: Revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 642-657.

Ramchandani, P., Joughin, C. & Zwi, M. (2002). Attention deficit hyperactivity disorder in children. Clinical Evidence, 9, 318-327.

Remschmidt, H. by the Global ADHD Working Group (2005) Global consensus on ADHD/HKD. European Child and Adolescent Psychiatry, 14, 127-137.

Rosca-Rebaudengo, P., Dusrt, R. & Dickman, M. (2000) Adult attention deficit hyperactivity disorder and comorbidity. International Journal of Psychiatry in Clinical Practice, 4, 35-39.

Rowland, A.S., Lesesne, C.A., & Abramowitz, A.J. (2002) The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view. Mental Retardation and Developmental Disabilities Research Reviews, 8, 162-70.

Salmon, G., Cleave, H., and Samuel, C. (2006) Development of multi-agency referral pathways for ADHD, DCD and ASD: Reflections on the process and suggestions for new ways of working. Clinical Child Psychology and Psychiatry, 11, 63-81.

Scottish Intercollegiate Guidelines Network (2001) Attention Deficit and Hyperactivity Disorders in Children and Young People. A National Clinical Guideline, SIGN.

Sonuga-Barke, E., Daley, D., Thompson, M., Laver-Bradbury, C. & Weeks, A. (2001). Parent-based therapies for preschool attention-deficit/hyperactivity disorder: A randomized controlled trial with a community sample. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 402-408.

Smits, M.G. et al (2001) Melatonin for chronic sleep onset insomnia in children: a randomized placebo-controlled trial. Journal of Child Neurology, 16, 86-92.

Sumner, C.S et al. ((2005) Atomoxetine treatment for pediatric patients with ADHD and comorbid anxiety. Presented at Annual Meeting of the American psychiatric Association; may 21-26; Atlanta.

Swanson, J.M., Sergeant, J.A., Taylor, E., Sonuga-Barke, E.J..S, Jensen, P.S. and Cantwell, D.P. (1998). Attention-deficit hyperactivity disorder and hyperkinetic disorder. The Lancet, 351, 429-433.

Swanson, J., Gupta, S., Guinta, D. et al, (1999) Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children. Clin Pharmacol Ther, 66, 295-305.

Szatmari, P., Offord, D.R. & Boyle, M.H. (1989) Correlates associated impairments and patterns of service utilization of children with attention deficit hyperactivity disorders: Findings from the Ontario child health study. Journal of Child Psychology and Psychiatry, 30, 205-217.

Taylor E, Dopfner M, Sergeant J, et al. (2004) European clinical guidelines for hyperkinetic disorder- first upgrade. European Child and Adolescent Psychiatry, 13 (supplement 1), 7-30.

Thapar, A., Holmes, J., Poulton, K. & Harrington, R. (1999). Genetic basis of attention deficit and hyperactivity. British Journal of Psychiatry, 174, 105-111.

Toone, B.K. & Van der Linden, G.J.H (1997). Attention-deficit hyperactivity disorder or hyperkinetic disorder in adults. British Journal of Psychiatry, 170, 489-91.

Welsh Assembly Government (2002) Special Educational Needs Code of Practice for Wales. National Assembly for Wales.

World Health Organisation (1992). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. WHO: Geneva.

Zwi, M. & York, A. (2004) Attention-deficit hyperactivity disorder in adults: validity unknown. Advances in Psychiatric Practice, 10, 248-259.